J. Goka

发表

Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection.

G. Alexander, N. Sheron, H. Daniels, 1991, Journal of hepatology.

Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics

N. Sheron, Roger Williams, G. Alexander, 2001 .

Zamifenacin (UK‐76, 654), a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome

F. Campbell, L. Houghton, J. Rogers, 1997, Alimentary pharmacology & therapeutics.

Are urodynamic tests useful tools for the initial conservative management of non-neurogenic urinary incontinence? A review of the literature.

A. Wein, F. Parazzini, W. Artibani, 2003, European urology.

Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation.

R. Williams, G. Bird, J. Goka, 1990, Journal of neurology, neurosurgery, and psychiatry.

Clearance and tissue distribution of staphylococcal enterotoxin A in the rat and potential use of adsorbents for removal from plasma.

M. Nagaki, R. Hughes, R. Williams, 1993, Journal of medical microbiology.

Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis.

G. Alexander, N. Sheron, R. Williams, 1991, Clinical and experimental immunology.

Increased plasma tumour necrosis factor alpha in severe alcoholic hepatitis

G. Alexander, Roger Williams, N. Sheron, 1990 .

Plasma inhibitory activity against tumour necrosis factor in fulminant hepatic failure.

N. Sheron, R. Hughes, R. Williams, 1996, Clinical science.

Assessment of an electronic daily diary in patients with overactive bladder

P. Quinn, J. Goka, H. Richardson, 2003, BJU international.

Plasma cytokine levels in fulminant hepatic failure: Associations with multi-organ failure

N. Sheron, Roger Williams, G. Alexander, 1991 .

Nomenclature of urinary incontinence.

E. Colli, J. Goka, 2000, Neurourology and urodynamics.